US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quantum Biopharma Ltd.

9.08

+0.33503.83%

Post-market: 9.00-0.0750-0.83%18:06 EDT

Volume:189.24K

Turnover:1.73M

Market Cap:20.87M

PE:-0.73

High:9.45

Open:8.60

Low:8.60

Close:8.74

Loading ...

Overview Company News Filings

Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial

Quantum BioPharma Provides Corporate Update

Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302

Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies

Quantum Biopharma (QNTM) Generating A Significant Buzz with Shares Up 230% YTD

Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs

Dow Edges Higher; US Weekly Jobless Claims Increase

QNTM Stock trading resumes

QNTM Stock trading halted, volatility trading pause

Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study

Gold Moves Higher; Estée Lauder Shares Slide

Quantum BioPharma's Unbuzzd Proven to Accelerate Alcohol Metabolism in Clinical Trial; Shares Jump

MT Newswires Live

US Stocks Mixed; PepsiCo Posts Downbeat Sales

Investor Sentiment Muted Amid China's Retaliatory Tariffs, Stifling US Equity Futures Pre-Bell

MT Newswires Live

Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial

Quantum BioPharma to be in court with Raza Bokhari on January 24

Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates

ACCESS Newswire

Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM

Quantum Biopharma Ltd. Approved to Dual List on Upstream

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/QNTM/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"QNTM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNTM\",,,,,undefined,":{"symbol":"QNTM","market":"US","secType":"STK","nameCN":"Quantum Biopharma Ltd.","latestPrice":9.075,"timestamp":1746820800000,"preClose":8.74,"halted":0,"volume":189242,"hourTrading":{"tag":"盘后","latestPrice":9,"preClose":9.075,"latestTime":"18:06 EDT","volume":2116,"amount":19062.999564,"timestamp":1746828384017},"delay":0,"floatShares":1944300,"shares":2299514,"eps":-12.492258,"marketStatus":"Post-Mkt","change":0.335,"latestTime":"05-09 18:34:03 EDT","open":8.6,"high":9.45,"low":8.6,"amount":1733481.132218,"amplitude":0.097254,"askPrice":9.24,"askSize":10,"bidPrice":9,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-12.492258,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746835200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":8.74,"preHourTrading":{"tag":"盘前","latestPrice":8.71,"preClose":8.74,"latestTime":"09:23 EDT","volume":892,"amount":7843.580784000001,"timestamp":1746796999386},"postHourTrading":{"tag":"盘后","latestPrice":9,"preClose":9.075,"latestTime":"18:06 EDT","volume":2116,"amount":19062.999564,"timestamp":1746828384017},"volumeRatio":1.277402},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"QNTM\",,,,,undefined,":{"symbol":"QNTM","floatShares":1944300,"roa":"-58.31%","roe":"-127.76%","lyrEps":-12.492258,"volumeRatio":1.277402,"shares":2299514,"dividePrice":0,"high":9.45,"amplitude":0.097254,"preClose":8.74,"low":8.6,"week52Low":2.7,"pbRate":"1.82","week52High":25.35,"institutionHeld":0,"latestPrice":9.075,"eps":-12.492258,"divideRate":0,"volume":189242,"delay":0,"ttmEps":-12.492258,"open":8.6,"prevYearClose":3.68,"prevWeekClose":7.75,"prevMonthClose":6.51,"prevQuarterClose":7.71,"fiveDayClose":7.75,"twentyDayClose":6.69,"sixtyDayClose":11.51},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"QNTM\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2519638156","title":"Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2519638156","media":"TipRanks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519638156?lang=en_us&edition=fundamental","pubTime":"2025-03-14 23:40","pubTimestamp":1741966809,"startTime":"0","endTime":"0","summary":"In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a dosing initiation, a development expansion and a distribution agreement.Discover stocks' market position with detailed  competitor analyses.MIRA EXPANDS KETAMIR-2 DEVELOPMENT WITH TOPICAL: On Thursday, MIRA Pharmaceuticals  announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain. This expands the company’s pain management portfolio beyond its ongoing Ketamir-2 oral treatment for neuropathic pain, offering a novel, targeted approach for localized pain relief. The topical treatment of Ketamir-2 is designed for slow release, delivering targeted pain relief directly at the application site while minimizing systemic exposure and side effects.“The development of both an oral and topical formulation of Ketamir-2 significantly expands our pipeline and enhances the value proposition of MIRA,” stated Erez Aminov, CEO . “By adv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/psychedelic-atai-reports-dosing-first-154009720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["RVVTF","DRUG","AGNPF","BK4202","BK4168","BK4547","QNTM","FLHLF","CYBN","BK4539","BK4007","KTTA","SILO","CMPS","ENTBF","ENVB","BK4139","GHRS","OPTHF","MYCOF","CMND","NRXP","SEEL","NUMIF","PSYGF","RLMD","IXHL","ALID","SNPX","ATAI","MNMD","BETRF","MIRA","PBM","MDXXF","PHRRF","SPRC"],"gpt_icon":0},{"id":"2517959834","title":"Quantum BioPharma Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2517959834","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517959834?lang=en_us&edition=fundamental","pubTime":"2025-03-08 09:00","pubTimestamp":1741395600,"startTime":"0","endTime":"0","summary":"Toronto, Ontario-- - Quantum BioPharma Ltd.    , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce the following corporate updates.Effective today, the Company has cancelled an aggregate of 7,692 warrants  to purchase class B subordinate voting shares in the capital of the Company , which were previously granted to Michael  Zapolin. The Company and Mr. Zapolin entered into a warrant cancellation agreement, pursuant to which Mr. Zapolin agreed to cancel the Warrants.Management had reviewed Mr. Zapolin's outstanding Warrants and determined that the Warrants granted to Mr. Zapolin no longer represented a realistic incentive to motivate Mr. Zapolin.The Company also announces the grant of 7,692 stock options to acquire Class B Shares  to Mr. Zapolin  pursuant to the Company's equity incentive plan, with an exercise price of C$6.60 per Class B Share and an expiry date of March 7, 2027.The securities being offered ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/quantum-biopharma-provides-corporate-010000421.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/quantum-biopharma-provides-corporate-010000421.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4555","BK4596","QNTM","BK4007","BK4099","LCID","BK4551"],"gpt_icon":0},{"id":"2514834695","title":"Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302","url":"https://stock-news.laohu8.com/highlight/detail?id=2514834695","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514834695?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:30","pubTimestamp":1740573000,"startTime":"0","endTime":"0","summary":"Safety Review Committee Found No Safety Concerns Following Milestone Trial TORONTO, Feb.  26, 2025  (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharm","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/26/3032821/0/en/Quantum-Biopharma-Announces-Completion-of-the-Phase-1-Multiple-Ascending-Dose-Clinical-Trial-for-its-Experimental-Multiple-Sclerosis-Drug-Lucid-21-302.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2271345857.HKD","LU1989772923.USD","LU0912757837.SGD","LU0158827781.USD","LU1363072403.SGD","LU1989772840.SGD","LU2357305700.SGD","BK4596","IE00BKVL7J92.USD","LU2111349929.HKD","LU0098860793.USD","BK4555","BK4588","LU0106831901.USD","BK4504","LU2028103732.USD","LU2347655156.SGD","LU0795875086.SGD","LU1732799900.SGD","LU1162221912.USD","LU2023251221.USD","QNTM","LU0971096721.USD","BK4581","LU1732800096.USD","LU0006306889.USD","IE00BZ1G4Q59.USD","LU1074936037.SGD","LU1720051017.SGD","BK4585","LU0795875169.SGD","BK4099","BK4127","BK4007","LU1548497426.USD","BK4516","BK4551","LCID","LU0314104364.USD","LU1668664300.SGD","LU2089283258.USD","LU0158827948.USD","LU0267386448.USD","LU0320765646.SGD","LU1720051108.HKD","BK4534","LU0106261372.USD","LU2089284900.SGD","LU0225283273.USD","LU2133065610.SGD"],"gpt_icon":0},{"id":"2512315488","title":"Quantum BioPharma Continues to Diversify its Treasury with the Purchase of Another USD $1,000,000 Worth of Bitcoin (BTC) and Other Cryptocurrencies","url":"https://stock-news.laohu8.com/highlight/detail?id=2512315488","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512315488?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:30","pubTimestamp":1739881800,"startTime":"0","endTime":"0","summary":"TORONTO, Feb.  18, 2025  (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that after receiving approval ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3027726/0/en/Quantum-BioPharma-Continues-to-Diversify-its-Treasury-with-the-Purchase-of-Another-USD-1-000-000-Worth-of-Bitcoin-BTC-and-Other-Cryptocurrencies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USD","03008","09042","QNTM","BK4551","09008","LCID","BK4099","BTC","03439","09439","BK4555","BK4007","03042","BK4596"],"gpt_icon":1},{"id":"2510901379","title":"Quantum Biopharma (QNTM) Generating A Significant Buzz with Shares Up 230% YTD","url":"https://stock-news.laohu8.com/highlight/detail?id=2510901379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510901379?lang=en_us&edition=fundamental","pubTime":"2025-02-12 20:59","pubTimestamp":1739365156,"startTime":"0","endTime":"0","summary":"Biopharmaceutical company Quantum BioPharma ($QNTM) has seen its stock rocket up roughly 230% in the past month. The company holds a 25.71% stake i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/quantum-biopharma-qntm-generating-a-significant-buzz-with-shares-up-230-ytd?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/quantum-biopharma-qntm-generating-a-significant-buzz-with-shares-up-230-ytd?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNTM"],"gpt_icon":0},{"id":"2510833993","title":"Quantum Biopharma Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2510833993","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510833993?lang=en_us&edition=fundamental","pubTime":"2025-02-11 20:30","pubTimestamp":1739277000,"startTime":"0","endTime":"0","summary":"TORONTO, Feb.  11, 2025  (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/11/3024056/0/en/Quantum-Biopharma-Engages-MZ-Group-to-Lead-Strategic-Investor-Relations-and-Shareholder-Communications-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LCID","BK4099","BK4551","QNTM","BK4596","BK4555"],"gpt_icon":1},{"id":"2510885134","title":"Quantum Biopharma Engages Enterprise Canada and Empire Market Ventures to Lead Public Communications and Investor Awareness Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2510885134","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510885134?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:30","pubTimestamp":1739190600,"startTime":"0","endTime":"0","summary":"Management has made this decision following a thorough review of capital on hand and allocated these resources to the Agencies to conduct public relations and investor awareness activities on its behalf.Enterprise is based at 595 Bay Street, Suite 1202, Toronto, Ontario, Canada. Enterprise has been engaged for an indefinite period effective December 18, 2024 . The Enterprise Agreement is structured in three phases, with C$10,000 paid to Enterprise at the start of Phase 1, C$2,500 on the completion of Phase 1, and C$5,000 due monthly as a public relations retainer .Enterprise will be assisting the Company with its public relations strategy, which includes developing the Company’s narrative, key messages, and pitching strategies with identified targets. Also, Enterprise will provide the Company with ongoing public relationships support, which includes building relationships with media, story ideation, and pitching for specific projects or initiatives.“This is an exciting time for Quantum","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/quantum-biopharma-engages-enterprise-canada-123000618.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LCID","BK4099","BK4596","BK4555","QNTM","BK4551","BK4007"],"gpt_icon":1},{"id":"2509277765","title":"Dow Edges Higher; US Weekly Jobless Claims Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277765","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509277765?lang=en_us&edition=fundamental","pubTime":"2025-02-06 23:06","pubTimestamp":1738854417,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"d692b68f53e736a66ee6c4966456b3a5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/02/43531523/dow-edges-higher-us-weekly-jobless-claims-increase","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RETO","LIPO","BK4139","BK4007","AVGR","SQQQ","BK4011",".IXIC","TQQQ","QNTM","BK4588","QID","BK4082","BK4585","USAW.SI","NVIW.SI","USJW.SI","APPS","QLD","MNQmain","TSYW.SI","BK4023","SRTS","PSQ","NQmain"],"gpt_icon":1},{"id":"2509270857","title":"QNTM Stock trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2509270857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509270857?lang=en_us&edition=fundamental","pubTime":"2025-02-06 22:55","pubTimestamp":1738853736,"startTime":"0","endTime":"0","summary":"09:52 EST QNTM Stock trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/qntm-stock-trading-resumes-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/qntm-stock-trading-resumes-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNTM","BK4007"],"gpt_icon":0},{"id":"2509278272","title":"QNTM Stock trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2509278272","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509278272?lang=en_us&edition=fundamental","pubTime":"2025-02-06 22:45","pubTimestamp":1738853142,"startTime":"0","endTime":"0","summary":"09:42 EST QNTM Stock trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving breaking...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/qntm-stock-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/qntm-stock-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","QNTM"],"gpt_icon":0},{"id":"2509220436","title":"Quantum Biopharma Licensee Celly Nutrition Retains Leading New York Investment Bank to Advise on Capital Raise and Possible Initial Public Offering Following Highly Positive Results from unbuzzd™ Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2509220436","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509220436?lang=en_us&edition=fundamental","pubTime":"2025-02-06 20:30","pubTimestamp":1738845000,"startTime":"0","endTime":"0","summary":"TORONTO, Feb.  06, 2025  (GLOBE NEWSWIRE) -- BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to bui","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/06/3021946/0/en/Quantum-Biopharma-Licensee-Celly-Nutrition-Retains-Leading-New-York-Investment-Bank-to-Advise-on-Capital-Raise-and-Possible-Initial-Public-Offering-Following-Highly-Positive-Result.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4007","QNTM","BK4099","BK4555","LCID","BK4596"],"gpt_icon":0},{"id":"2509498478","title":"Gold Moves Higher; Estée Lauder Shares Slide","url":"https://stock-news.laohu8.com/highlight/detail?id=2509498478","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509498478?lang=en_us&edition=fundamental","pubTime":"2025-02-05 03:02","pubTimestamp":1738695775,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/02/43474623/gold-moves-higher-estee-lauder-shares-slide","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4585","NQmain","LU1861559042.SGD","NVIW.SI","UPC","USAW.SI","BK4007","LU2362541513.USD","SQQQ","QID","TSYW.SI","LU1303367103.USD","LU1983260115.SGD","BK4096","ATKR","BK4558","QLD","QNTM","LU1861558580.USD","BK4108","USJW.SI","LU2404859667.USD","LU1559883803.SGD","BK4533","BK4547","LU0566484027.USD","SPOT","PSQ","LU0690374615.EUR","BK4023","BK4588","LU2404859741.USD","LU2552382132.HKD","LU1804176565.USD","LU2362541273.HKD","LU2552382058.USD","LU2552382215.SGD",".IXIC","BK4571","PLTR","LU2362540622.SGD","LU1861215975.USD","LU2265009873.SGD","EL","BK4543","LU2290526834.HKD","TQQQ","MNQmain"],"gpt_icon":1},{"id":"2508465602","title":"Quantum BioPharma's Unbuzzd Proven to Accelerate Alcohol Metabolism in Clinical Trial; Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2508465602","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508465602?lang=en_us&edition=fundamental","pubTime":"2025-02-04 23:52","pubTimestamp":1738684351,"startTime":"0","endTime":"0","summary":"Quantum BioPharma  said Tuesday that a trial of its dietary supplement, Unbuzzd, confirmed it accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration, and reduces symptoms of intoxication, impairment, and hangover.The study, which examined Unbuzzd's impact on alcohol intoxication and metabolism, found the results to be statistically significant compared to a placebo.The effects were noticeable within 30 minutes of consuming the dissolved powder. The supplement was well-tolerated, with no reported adverse effects.The shares of Quantum BioPharma surged nearly 53% in recent trading.Price: 4.86, Change: +1.68, Percent Change: +52.83","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","QNTM","AAQC"],"gpt_icon":1},{"id":"2508572214","title":"US Stocks Mixed; PepsiCo Posts Downbeat Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2508572214","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508572214?lang=en_us&edition=fundamental","pubTime":"2025-02-04 22:44","pubTimestamp":1738680249,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/02/43464430/us-stocks-mixed-pepsico-posts-downbeat-sales","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QNTM","AZTR","OMGA","PEP","EJH","UPC","VLCN"],"gpt_icon":0},{"id":"2508345439","title":"Investor Sentiment Muted Amid China's Retaliatory Tariffs, Stifling US Equity Futures Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2508345439","media":"MT Newswires Live","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508345439?lang=en_us&edition=fundamental","pubTime":"2025-02-04 22:01","pubTimestamp":1738677711,"startTime":"0","endTime":"0","summary":"US equity futures were flat ahead of Tuesday's opening bell as traders assessed the potential impact of China's retaliatory tariffs on US goods.Dow Jones Industrial Average futures slipped 0.2%, S&P 5","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0266013472.USD","LU1291159041.SGD","QNTM","LU2361044865.SGD","USJW.SI","LU0965508806.USD","LU1974910355.USD","LU1066051811.HKD","QID","LU1699723380.USD","DDM","QLD","LU1061106388.HKD","IE00B1BXHZ80.USD","DOG","MRK","BK4007","EQR","LU1116320737.USD","LU2023250504.SGD","DXD","PSQ","TQQQ","LU0690374615.EUR","SPOT",".DJI","NQmain","TSYW.SI","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0006306889.USD","SDOW","SQQQ",".IXIC","MNQmain","SG9999002224.SGD","DJX","EL","LU2089984988.USD","LU1430594728.SGD","IE00BLSP4239.USD","NVIW.SI","UDOW","LU1303367103.USD",".SPX","LU0985320562.USD","USAW.SI","LU1066051498.USD","BK4588"],"gpt_icon":1},{"id":"2508458656","title":"Quantum Biopharma Announces the Success of unbuzzd™ Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2508458656","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508458656?lang=en_us&edition=fundamental","pubTime":"2025-02-04 20:03","pubTimestamp":1738670580,"startTime":"0","endTime":"0","summary":"Trial Confirms unbuzzd Dramatically Accelerates Alcohol Metabolism, Speeds the Reduction of Blood Alcohol Concentration, and Reduces Symptoms of Intoxication, Impairment and HangoverTORONTO, Feb.  04,","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/04/3020150/0/en/Quantum-Biopharma-Announces-the-Success-of-unbuzzd-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4007","QNTM","BK4551","BK4555","BK4596","LCID"],"gpt_icon":1},{"id":"2504150858","title":"Quantum BioPharma to be in court with Raza Bokhari on January 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2504150858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504150858?lang=en_us&edition=fundamental","pubTime":"2025-01-17 20:40","pubTimestamp":1737117650,"startTime":"0","endTime":"0","summary":"Quantum BioPharma (QNTM) will be back in the Ontario Superior Court of Justice on January 24, 2025. Quantum BioPharma is seeking a Court Order decl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/quantum-biopharma-to-be-in-court-with-raza-bokhari-on-january-24?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/quantum-biopharma-to-be-in-court-with-raza-bokhari-on-january-24?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QNTM","BK4007"],"gpt_icon":0},{"id":"2504316330","title":"Quantum Biopharma in Court With Dr. Raza Bokhari on January 24, 2025 Seeking a Court Order to Declare Him to Be a Vexatious Litigant and Other Litigation Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2504316330","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504316330?lang=en_us&edition=fundamental","pubTime":"2025-01-17 20:30","pubTimestamp":1737117000,"startTime":"0","endTime":"0","summary":"Awards in favour of Quantum BioPharma Total Approximately $3 Million. TORONTO, ON / ACCESS Newswire / January 17, 2025 / Quantum BioPharma Ltd.   , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announced that it will be back in the Ontario Superior Court of Justice on January 24, 2025. Quantum BioPharma is seeking a Court Order declaring Dr. Raza Bokhari, current CEO of Medicus Pharma, Ltd., to be a vexatious litigant. Dr. Raza Bokhari was CEO of FSD Pharma Inc.   now Quantum BioPharma, in 2019 and was terminated for cause in July 2021.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/quantum-biopharma-court-dr-raza-123000719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4099","BK4007","QNTM","BK4596","LCID","BK4551","BK4555"],"gpt_icon":0},{"id":"2503573773","title":"Quantum Biopharma Ltd. Now Trading on Upstream Under QNTM","url":"https://stock-news.laohu8.com/highlight/detail?id=2503573773","media":"ACCESSWIRE","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503573773?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861400,"startTime":"0","endTime":"0","summary":"Quantum BioPharma Ltd. Dual Lists on Upstream's Global Securities Trading App. TORONTO, ON / ACCESSWIRE / January 14, 2025 / Quantum BioPharma Ltd.  , a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, will become available Tuesday, January 14 at 10:00am EST under the ticker symbol ‘QNTM' on Upstream, a MERJ Exchange market and global securities trading app. The dual listing on Upstream works to provide international investors around the world with streamlined access to Quantum shares using just an app. Quantum will continue to trade on the Nasdaq, Canadian Securities Exchange and Frankfurt exchanges.About Quantum BioPharma Ltd.Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/quantum-biopharma-ltd-now-trading-133000983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QNTM","BK4551","BK4596","BK4099","BK4007","BK4555"],"gpt_icon":1},{"id":"2501204355","title":"Quantum Biopharma Ltd. Approved to Dual List on Upstream","url":"https://stock-news.laohu8.com/highlight/detail?id=2501204355","media":"ACCESSWIRE","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501204355?lang=en_us&edition=fundamental","pubTime":"2025-01-07 21:30","pubTimestamp":1736256600,"startTime":"0","endTime":"0","summary":"Trading to become available January 14th under 'QNTM'. TORONTO, ONTARIO / ACCESSWIRE / January 7, 2025 / Quantum BioPharma Ltd.  , today announced its approval to dual list its shares on Upstream, a MERJ Exchange market and global securities trading app. Trading becomes available on Upstream Tuesday, January 14, 2025, at 10:00am ET under the ticker symbol ‘QNTM.'. Existing non-U.S. shareholders may initiate the transfer of their shares by opening Upstream, tapping Investor, Manage Securities, Deposit Securities, then entering the ticker symbol ‘QNTM' and the number of shares to deposit, and tapping Submit. Next, investors enter their brokerage firm name and brokerage account number, then tap Submit. Lastly, investors tap Add E-Signature, sign their name on the screen using their finger, tap Done, and then tap Sign.Quantum BioPharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerati","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/quantum-biopharma-ltd-approved-dual-133000872.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4596","QNTM","BK4007","BK4099","BK4551","BK4555"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/QNTM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-15","symbol":"QNTM","defaultRemindTime":1723728600000,"type":"split","dateTimestamp":1723694400000,"forFactor":65,"toFactor":1,"ratio":65},{"market":"US","date":"2024-08-14","symbol":"QNTM","fiscalQuarterEnding":"2024/06","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"pre","actualEps":-0.08},{"market":"US","date":"2024-05-14","symbol":"QNTM","fiscalQuarterEnding":"2024/03","expectedEps":-0.05,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.05},{"market":"US","date":"2024-03-28","symbol":"QNTM","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"post","actualEps":-0.04},{"market":"US","date":"2023-11-14","symbol":"QNTM","fiscalQuarterEnding":"2023/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1699938000000,"reportTimeType":"post","actualEps":-0.03}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"QNTM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"QNTM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1745899200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/QNTM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"QNTM","date":"2025-05-08","current":-1.579122,"percent":0.066667,"low":-2.690643,"twenty":-1.303559,"median":-0.960529,"eighty":-0.708598,"high":-0.546516,"avg":-1.038699,"sd":0.376454,"marketCap":22427834.69},"quantilePoints":[{"date":"2024-08-16","current":-0.603659,"twenty":-0.603659,"median":-0.603659,"eighty":-0.603659,"marketCap":4509122.69},{"date":"2024-08-23","current":-0.69618,"twenty":-0.715087,"median":-0.702389,"eighty":-0.647248,"marketCap":5200216.8},{"date":"2024-08-30","current":-0.852638,"twenty":-0.775012,"median":-0.723053,"eighty":-0.69618,"marketCap":6368904.17},{"date":"2024-09-06","current":-0.700453,"twenty":-0.779153,"median":-0.715087,"eighty":-0.653758,"marketCap":5232131.53},{"date":"2024-09-13","current":-0.690425,"twenty":-0.744955,"median":-0.704525,"eighty":-0.66483,"marketCap":5157233.86},{"date":"2024-09-20","current":-0.993485,"twenty":-0.779153,"median":-0.708429,"eighty":-0.669437,"marketCap":7420982.26},{"date":"2024-09-27","current":-0.939399,"twenty":-0.944216,"median":-0.716816,"eighty":-0.671749,"marketCap":7016975.73},{"date":"2024-10-04","current":-0.974979,"twenty":-0.964556,"median":-0.73591,"eighty":-0.672431,"marketCap":7282751.47},{"date":"2024-10-11","current":-1.090369,"twenty":-0.996068,"median":-0.785363,"eighty":-0.686838,"marketCap":8144673.49},{"date":"2024-10-18","current":-1.45785,"twenty":-1.05098,"median":-0.878475,"eighty":-0.692178,"marketCap":10889624.45},{"date":"2024-10-25","current":-1.442036,"twenty":-1.139524,"median":-0.944288,"eighty":-0.695467,"marketCap":10771499.96},{"date":"2024-10-31","current":-1.205452,"twenty":-1.188827,"median":-0.956387,"eighty":-0.698744,"marketCap":9004299.96},{"date":"2024-11-08","current":-1.349307,"twenty":-1.226202,"median":-0.974979,"eighty":-0.705239,"marketCap":10078847.03},{"date":"2024-11-15","current":-0.935735,"twenty":-1.275577,"median":-0.971909,"eighty":-0.70853,"marketCap":9579098.88},{"date":"2024-11-22","current":-0.960529,"twenty":-1.226202,"median":-0.963485,"eighty":-0.712491,"marketCap":9832911.8},{"date":"2024-11-29","current":-0.869873,"twenty":-1.213599,"median":-0.963485,"eighty":-0.716471,"marketCap":8904877.06},{"date":"2024-12-06","current":-0.815226,"twenty":-1.195279,"median":-0.949234,"eighty":-0.720349,"marketCap":8345447.87},{"date":"2024-12-13","current":-0.759973,"twenty":-1.179109,"median":-0.943869,"eighty":-0.728196,"marketCap":7779827.58},{"date":"2024-12-20","current":-0.685739,"twenty":-1.175332,"median":-0.939333,"eighty":-0.720349,"marketCap":7019890.91},{"date":"2024-12-27","current":-0.616825,"twenty":-1.165719,"median":-0.934788,"eighty":-0.708463,"marketCap":6314424.32},{"date":"2025-01-03","current":-0.759721,"twenty":-1.141743,"median":-0.927085,"eighty":-0.708429,"marketCap":7777249.84},{"date":"2025-01-10","current":-0.742133,"twenty":-1.141141,"median":-0.878991,"eighty":-0.708564,"marketCap":7597197.4},{"date":"2025-01-17","current":-0.619978,"twenty":-1.139524,"median":-0.852638,"eighty":-0.692178,"marketCap":6346706.26},{"date":"2025-01-24","current":-0.619485,"twenty":-1.109884,"median":-0.815226,"eighty":-0.676014,"marketCap":6341654.9},{"date":"2025-01-31","current":-0.561714,"twenty":-1.082749,"median":-0.80554,"eighty":-0.668876,"marketCap":5750259.21},{"date":"2025-02-07","current":-2.690643,"twenty":-1.13989,"median":-0.808855,"eighty":-0.664161,"marketCap":27544054.02},{"date":"2025-02-14","current":-1.986183,"twenty":-1.178654,"median":-0.820792,"eighty":-0.668876,"marketCap":20332510.29},{"date":"2025-02-21","current":-1.288506,"twenty":-1.229787,"median":-0.861255,"eighty":-0.670874,"marketCap":13190405.23},{"date":"2025-02-28","current":-0.926203,"twenty":-1.213599,"median":-0.879508,"eighty":-0.672308,"marketCap":9481520.11},{"date":"2025-03-07","current":-0.836122,"twenty":-1.195279,"median":-0.874174,"eighty":-0.673618,"marketCap":8559365.07},{"date":"2025-03-14","current":-0.835912,"twenty":-1.179109,"median":-0.852638,"eighty":-0.675778,"marketCap":8557218.89},{"date":"2025-03-21","current":-1.273806,"twenty":-1.21489,"median":-0.874174,"eighty":-0.680186,"marketCap":13039931.07},{"date":"2025-03-28","current":-1.564993,"twenty":-1.229787,"median":-0.90884,"eighty":-0.687613,"marketCap":16020800.96},{"date":"2025-04-04","current":-1.52667,"twenty":-1.237788,"median":-0.92592,"eighty":-0.691301,"marketCap":21682873.03},{"date":"2025-04-11","current":-1.273742,"twenty":-1.263262,"median":-0.933841,"eighty":-0.694042,"marketCap":18090602.39},{"date":"2025-04-17","current":-1.168311,"twenty":-1.270743,"median":-0.939267,"eighty":-0.697035,"marketCap":16593197.2},{"date":"2025-04-25","current":-1.303484,"twenty":-1.273793,"median":-0.943051,"eighty":-0.702048,"marketCap":18513021.69},{"date":"2025-05-02","current":-1.294143,"twenty":-1.300404,"median":-0.949177,"eighty":-0.708463,"marketCap":18380352.73},{"date":"2025-05-08","current":-1.579122,"twenty":-1.303559,"median":-0.960529,"eighty":-0.708598,"marketCap":22427834.69}],"updateTime":1746830043788}}}